Penumbra, Inc. Reports First Quarter 2026 Financial Results
Go back to Penumbra, Inc. Reports First Quarter 2026 Financial Results| Boston Scientific (NYSE: BSX) | Delayed: 41.99 +0.41 (0.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.58 | 52 Week High | $24.79 | |||
| Open | $41.50 | 52 Week Low | $15.67 | |||
| Day High | $42.17 | P/E | N/A | |||
| Day Low | $41.44 | EPS | $-0.09 | |||
| Volume | 2,325,782 | |||||
| (NYSE: PEN) | Delayed: 316.94 +0.59 (0.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $316.35 | 52 Week High | $79.49 | |||
| Open | $316.61 | 52 Week Low | $40.23 | |||
| Day High | $317.22 | P/E | N/A | |||
| Day Low | $316.61 | EPS | $0.00 | |||
| Volume | 32,028 | |||||



